Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Form X-17A-5 CANTOR FITZGERALD & CO. For: Dec 31
-
Amryt (AMYT) PT Lowered to $25 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Amarin Corporation (AMRN) at Overweight, "Street is Underestimating Multi-billion Dollar Opportunity for Vascepa/Vazkepa"
-
Novavax (NVAX) Stock Falls 6% on Weak Sales Guidance, Analyst Remains Positive
-
Heron Therapeutics (HRTX) PT Lowered to $20 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) at Overweight, Pharm Business is Underappreciated, Expect Upwards Earnings Revisions and Multiple Expansion
-
Cantor Fitzgerald Reiterates Ardelyx (ARDX) at Overweight, Peak Sales Potential of Pipeline is Underappreciated
-
Cantor Fitzgerald Reiterates Overweight Rating on Humanigen (HGEN), Expects Upward Earnings Revisions
-
C5 Acquisition Corporation Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing February 28, 2022
-
Cantor Fitzgerald Starts Journey Medical Corp. (DERM) at Overweight
-
Katapult Holdings (KPLT) PT Lowered to $4 at Cantor Fitzgerald
-
Delwinds Insurance Acquisition Corp. (DWIN) and FOXO Technologies Announce Merger Agreement
-
FOXO Technologies Inc. Enters Into Business Combination Agreement with Delwinds Insurance Acquisition Corp.
-
FOXO Technologies Inc. Enters Into Business Combination Agreement with Delwinds Insurance Acquisition Corp.
-
Orchid Island Capital Announces Fourth Quarter 2021 Results
-
Cantor Fitzgerald Reiterates Aclaris Therapeutis (ACRS) at Overweight, "Still a Lot of Value to be Unlocked in ACRS's Pipeline"
-
Troika Media (TRKA) Acquires Converge Direct for $125M
-
Troika Media Group to Acquire Converge Direct LLC, a Leading Digital and Offline Performance Media and Marketing Company, for $125 Million
-
Troika Media Group to Acquire Converge Direct LLC, a Leading Digital and Offline Performance Media and Marketing Company, for $125 Million
-
Troika Media Group to Acquire Converge Direct LLC, a Leading Digital and Offline Performance Media and Marketing Company, for $125 Million
-
Cantor Fitzgerald Reiterates Overweight Rating on Vaxcyte (PCVX), VAX-24 Study Patient Dosing Brings the Company Closer to Potential Commercialization
-
William Ferri Joins Cantor Fitzgerald to Lead Expansion of Asset Management Platform
-
UPDATE: Cantor Fitzgerald Starts Affimed Therapeutics (AFMD) at Overweight
-
Arcutis (ARQT) Reiterated at Overweight by Cantor Fitzgerald, Company's Opportunity to Become Medical Dermatology Leader Remains Underappreciated
-
Cantor Fitzgerald Reiterates Cutera (CUTR) at Overweight, Company's Comprehensive Portfolio of Innovative Solutions is Underappreciated, Expect Upward Earnings Revisions
-
Ocugen (OCGN) Prices 15.97M Share Offering at $3.35/sh
-
Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common Stock
-
Ocugen (OCGN) Announces Proposed Public Offering of Common Stock
-
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Novan (NOVN) at Overweight, Peak Sales of SB206 Underappreciated, Expect Upwards Earnings Revisions
-
High Tide Inc. (HITI:CN) (HITI) PT Lowered to Cdn$7.25 at Cantor Fitzgerald
-
Best Penny Stocks to Watch This Coming Week
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor Fitzgerald Downgrades BioDelivery Sciences International (BDSI) to Neutral on Pending Takeover
-
Aleafia Health Inc (AH:CN) (ALEAF) PT Lowered to Cdn$0.13 at Cantor Fitzgerald
-
Canopy Growth (WEED:CN) (CGC) PT Raised to Cdn$11 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts vTv Therapeutics (VTVT) at Overweight; Sees 800% Upside
-
Cantor Fitzgerald Starts Poseida Therapeutics, Inc (PSTX) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Oramed Pharma (ORMP) at Overweight
-
Cantor Fitzgerald Starts Iris Energy Ltd. (IREN) at Overweight
-
Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now
-
Insmed (INSM) PT Slashed to $53 at Cantor Fitzgerald, Lower Sales Forecast for Arikayce and Increased OpEx Weigh In
-
Cantor Fitzgerald Downgrades Coeur d'Alene Mines (CDE) to Hold, Following Earnings
-
Royal Gold (RGLD) PT Raised to $130 at Cantor Fitzgerald, Following Earnings
-
Johnson & Johnson (JNJ), Cidara Therapeutics (CDTX), Pfizer (PFE), and PDS Biotechnology (PDSB) - Cantor Fitzgerald's Top Flu Vaccine Candidates for 2022
-
Orchid Island Capital Announces February 2022 Monthly Dividend and January 31, 2022 RMBS Portfolio Characteristics
-
Spero Therapeutics (SPRO) Reiterated at Overweight by Cantor Fitzgerald, SPR206 Results Support Further Development, Expect Upward Earnings Revisions and Multiple Expansion
-
Zoetis (ZTS) Shares Pop on Earnings Beat, Analysts Positive
-
Cantor Fitzgerald Reiterates Zoetis (ZTS) at Overweight, Earnings Potential of Underlying Business is Still Underappreciated
-
CF Acquisition Corp. VI and Rumble Announce Filing of a Registration Statement in Connection with their Proposed Business Combination

